Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other financing activities (2020 - 2024)

Immuneering (IMRX) has 3 years of Other financing activities data on record, last reported at $40988.0 in Q4 2024.

  • For Q4 2024, Other financing activities changed N/A year-over-year to $40988.0; the TTM value through Dec 2024 reached $40988.0, down 85.43%, while the annual FY2024 figure was $40988.0, 79.88% down from the prior year.
  • Other financing activities reached $40988.0 in Q4 2024 per IMRX's latest filing, down from $226775.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $226775.0 in Q4 2022 and bottomed at $40988.0 in Q4 2024.
  • Average Other financing activities over 3 years is $134595.5, with a median of $135309.5 recorded in 2020.